These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 32622330)

  • 1. Dual Regulation of miR-34a and Notch Signaling in Triple-Negative Breast Cancer by Antibody/miRNA Nanocarriers.
    Valcourt DM; Day ES
    Mol Ther Nucleic Acids; 2020 Sep; 21():290-298. PubMed ID: 32622330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoparticle-Mediated Co-Delivery of Notch-1 Antibodies and ABT-737 as a Potent Treatment Strategy for Triple-Negative Breast Cancer.
    Valcourt DM; Dang MN; Scully MA; Day ES
    ACS Nano; 2020 Mar; 14(3):3378-3388. PubMed ID: 32083466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Layer-by-layer assembled PLGA nanoparticles carrying miR-34a cargo inhibit the proliferation and cell cycle progression of triple-negative breast cancer cells.
    Kapadia CH; Ioele SA; Day ES
    J Biomed Mater Res A; 2020 Mar; 108(3):601-613. PubMed ID: 31742868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photoresponsive miR-34a/Nanoshell Conjugates Enable Light-Triggered Gene Regulation to Impair the Function of Triple-Negative Breast Cancer Cells.
    Dang MN; Gomez Casas C; Day ES
    Nano Lett; 2021 Jan; 21(1):68-76. PubMed ID: 33306406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual Suppressive Effect of miR-34a on the FOXM1/eEF2-Kinase Axis Regulates Triple-Negative Breast Cancer Growth and Invasion.
    Bayraktar R; Ivan C; Bayraktar E; Kanlikilicer P; Kabil NN; Kahraman N; Mokhlis HA; Karakas D; Rodriguez-Aguayo C; Arslan A; Sheng J; Wong S; Lopez-Berestein G; Calin GA; Ozpolat B
    Clin Cancer Res; 2018 Sep; 24(17):4225-4241. PubMed ID: 29748184
    [No Abstract]   [Full Text] [Related]  

  • 6. Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer.
    Deng X; Cao M; Zhang J; Hu K; Yin Z; Zhou Z; Xiao X; Yang Y; Sheng W; Wu Y; Zeng Y
    Biomaterials; 2014 May; 35(14):4333-44. PubMed ID: 24565525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-34a Silences c-SRC to Attenuate Tumor Growth in Triple-Negative Breast Cancer.
    Adams BD; Wali VB; Cheng CJ; Inukai S; Booth CJ; Agarwal S; Rimm DL; Győrffy B; Santarpia L; Pusztai L; Saltzman WM; Slack FJ
    Cancer Res; 2016 Feb; 76(4):927-39. PubMed ID: 26676753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 downregulates PD-L1 expression via miR-34a to inhibit the growth of triple-negative breast cancer cells: a potential clinical immunotherapeutic target.
    Deng S; Wang M; Wang C; Zeng Y; Qin X; Tan Y; Liang B; Cao Y
    Mol Biol Rep; 2023 Jan; 50(1):577-587. PubMed ID: 36352176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanodiamond-based layer-by-layer nanohybrids mediate targeted delivery of miR-34a for triple negative breast cancer therapy.
    Xia Y; Deng X; Cao M; Liu S; Zhang X; Xiao X; Shen S; Hu Q; Sheng W
    RSC Adv; 2018 Apr; 8(25):13789-13797. PubMed ID: 35539318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NFIX Circular RNA Promotes Glioma Progression by Regulating miR-34a-5p via Notch Signaling Pathway.
    Xu H; Zhang Y; Qi L; Ding L; Jiang H; Yu H
    Front Mol Neurosci; 2018; 11():225. PubMed ID: 30072869
    [No Abstract]   [Full Text] [Related]  

  • 11. Layer-by-layer assembled gold nanoshells for the intracellular delivery of miR-34a.
    Goyal R; Kapadia CH; Melamed JR; Riley RS; Day ES
    Cell Mol Bioeng; 2018 Oct; 11(5):383-396. PubMed ID: 30555597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Notch1 in Tumor Microvascular Endothelial Cells and Tumoral miR-34a as Prognostic Markers in Locally Advanced Triple-Negative Breast Cancer.
    Kim D; Lee J; Kang J; Kim SH; Yoo TK; Oh S; Lee A
    J Breast Cancer; 2019 Dec; 22(4):562-578. PubMed ID: 31897330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-34a suppresses invasion through downregulation of Notch1 and Jagged1 in cervical carcinoma and choriocarcinoma cells.
    Pang RT; Leung CO; Ye TM; Liu W; Chiu PC; Lam KK; Lee KF; Yeung WS
    Carcinogenesis; 2010 Jun; 31(6):1037-44. PubMed ID: 20351093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia-induced down-regulation of microRNA-34a promotes EMT by targeting the Notch signaling pathway in tubular epithelial cells.
    Du R; Sun W; Xia L; Zhao A; Yu Y; Zhao L; Wang H; Huang C; Sun S
    PLoS One; 2012; 7(2):e30771. PubMed ID: 22363487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-34a regulates liver regeneration and the development of liver cancer in rats by targeting Notch signaling pathway.
    Wang XP; Zhou J; Han M; Chen CB; Zheng YT; He XS; Yuan XP
    Oncotarget; 2017 Feb; 8(8):13264-13276. PubMed ID: 28129650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PDL1 And LDHA act as ceRNAs in triple negative breast cancer by regulating miR-34a.
    Huang X; Xie X; Wang H; Xiao X; Yang L; Tian Z; Guo X; Zhang L; Tang H; Xie X
    J Exp Clin Cancer Res; 2017 Sep; 36(1):129. PubMed ID: 28915924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-delivery of 5-fluorouracil and miRNA-34a mimics by host-guest self-assembly nanocarriers for efficacious targeted therapy in colorectal cancer patient-derived tumor xenografts.
    Xu J; Zhang G; Luo X; Wang D; Zhou W; Zhang Y; Zhang W; Chen J; Meng Q; Chen E; Chen H; Song Z
    Theranostics; 2021; 11(5):2475-2489. PubMed ID: 33500737
    [No Abstract]   [Full Text] [Related]  

  • 18. miRNA-34a reduces neointima formation through inhibiting smooth muscle cell proliferation and migration.
    Chen Q; Yang F; Guo M; Wen G; Zhang C; Luong le A; Zhu J; Xiao Q; Zhang L
    J Mol Cell Cardiol; 2015 Dec; 89(Pt A):75-86. PubMed ID: 26493107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined Photosensitive Gene Therapy Effective Against Triple-Negative Breast Cancer in Mice Model.
    Hu Y; Wang D; Zhang T; Lei M; Luo Y; Chen Z; Li Y; Duan D; Zhang L; Zhu Y
    Int J Nanomedicine; 2024; 19():1809-1825. PubMed ID: 38414523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-34a suppresses the breast cancer stem cell-like characteristics by downregulating Notch1 pathway.
    Kang L; Mao J; Tao Y; Song B; Ma W; Lu Y; Zhao L; Li J; Yang B; Li L
    Cancer Sci; 2015 Jun; 106(6):700-708. PubMed ID: 25783790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.